These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
29. [Care of kidney transplant patients using different immunosuppressive drugs]. Yu PP Zhonghua Hu Li Za Zhi; 1987 Apr; 22(4):165-6. PubMed ID: 3308152 [No Abstract] [Full Text] [Related]
30. [Clinical relevance of N-acetylglucosaminidase determination in urine of kidney transplant recipients with and without cyclosporin A]. Loertscher R; Scholer A; Brunner F; Harder F; Thiel G Schweiz Med Wochenschr; 1982 Nov; 112(46):1658-64. PubMed ID: 6760389 [TBL] [Abstract][Full Text] [Related]
31. A study of eleven drug regimens using cyclosporin-A to suppress renal allograft rejection in the dog. Homan WP; French ME; Millard PR; Morris PJ Transplant Proc; 1981 Mar; 13(1 Pt 1):397-401. PubMed ID: 7022860 [No Abstract] [Full Text] [Related]
32. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function. Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658 [No Abstract] [Full Text] [Related]
36. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy. Häyry P; von Willebrand E; Ahonen J Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749 [TBL] [Abstract][Full Text] [Related]
37. [Macroangiopathy of a kidney graft caused by cyclosporin A]. Jurine N; Guérin C; Kalil C; Broyet C; Veyret C; Berthoux F Ann Radiol (Paris); 1989; 32(2):147-9. PubMed ID: 2667434 [TBL] [Abstract][Full Text] [Related]
38. Prognostic factors affecting graft and patient survival in cadaveric and living kidney transplantation. Kim SJ; Lee HH; Lee DS; Lee KW; Joh JW; Woo DH; Kwon GY; Oh HY; Kim YG; Huh WS; Kim DJ; Kim GS; Lee SK; Lee BB Transplant Proc; 2004 Sep; 36(7):2038-9. PubMed ID: 15518737 [TBL] [Abstract][Full Text] [Related]
39. Blood cyclosporin concentrations and renal allograft dysfunction. Lui SF; Varghese Z; Sweny P; Fernando ON; Moorhead JF Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1435. PubMed ID: 3099900 [No Abstract] [Full Text] [Related]
40. Management of advanced ovarian epithelial cancer in the renal transplant patient. Teneriello M; Farley J; Parker M; O'Connor D; Shaver T; Park R; Barnhill D Gynecol Oncol; 1993 Sep; 50(3):374-8. PubMed ID: 8406205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]